Synapse

← JHEP Reports

Papers in JHEP Reports

Page 10 · newest first

  1. Serum proteomics of adults with acute liver failure provides mechanistic insights and attractive prognostic biomarkersJHEP Reports · 2025
  2. Evolving epidemiology of HCC in SpainJHEP Reports · 2025
  3. Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesisJHEP Reports · 2025
  4. Protective value of ischemia-free liver transplantation on post-transplant acute kidney injuryJHEP Reports · 2025
  5. Macrophage ATG16L1 promotes liver regeneration after partial hepatectomyJHEP Reports · 2025
  6. PLOD1 promotes the malignancy of hepatocellular carcinoma by facilitating the NF-κB/IL-6/STAT3-dependent TCA cycleJHEP Reports · 2025
  7. Adapted hepatitis C virus clone infects innate immunity-deficient mouse hepatocytes with minimal human HCV entry factorsJHEP Reports · 2025
  8. Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trialJHEP Reports · 2025
  9. CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type IJHEP Reports · 2025
  10. Quality of life in patients with HBV infection: A systematic review and meta-analysisJHEP Reports · 2025
  11. Diversity and inclusion in chronic hepatitis B randomised controlled trials: A systematic meta-epidemiological reviewJHEP Reports · 2025
  12. Potential role of liver-resident CD3+ macrophages in HBV clearance in a mouse hepatitis B modelJHEP Reports · 2024
  13. Identifying emergency presentations of chronic liver disease using routinely collected administrative hospital dataJHEP Reports · 2024
  14. Statin use and liver-related prognosis among patients with MASLDJHEP Reports · 2024
  15. Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytesJHEP Reports · 2024
  16. Trans-splenic anterograde coil-assisted transvenous occlusion (TACATO) of bleeding gastric varices associated with gastrorenal shunts in cirrhosisJHEP Reports · 2024
  17. Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasisJHEP Reports · 2024
  18. LAPTM4B enhances the stemness of CD133+ liver cancer stem-like cells via WNT/β-catenin signalingJHEP Reports · 2024
  19. Hepatopulmonary syndrome in patients with porto-sinusoidal vascular disorder: Characteristics and outcomeJHEP Reports · 2024
  20. Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liverJHEP Reports · 2024
  21. QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosisJHEP Reports · 2024
  22. Identification and clinical implications of endogenous retrovirus elements suppressed by SETDB1 in hepatocellular carcinomaJHEP Reports · 2024
  23. Deep phenotyping of patients with MASLD upon high-intensity interval trainingJHEP Reports · 2024
  24. Unraveling the immune-activated tumor microenvironment correlated with clinical response to atezolizumab plus bevacizumab in advanced HCCJHEP Reports · 2024
  25. CPEB4 modulates liver cancer progression by translationally regulating hepcidin expression and sensitivity to ferroptosisJHEP Reports · 2024
  26. Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndromeJHEP Reports · 2024
  27. Non-invasive assessment of portal hypertension: Liver stiffness and beyondJHEP Reports · 2024
  28. Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDVJHEP Reports · 2024
  29. Monitoring of hepatitis E virus infection and replication by functional tagging of the ORF2 proteinJHEP Reports · 2024
  30. Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumabJHEP Reports · 2024
  31. Molecular MRI of T-cell immune response to cryoablation in immunologically hot vs. cold hepatocellular carcinomaJHEP Reports · 2024
  32. Primary sclerosing cholangitis–inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequenceJHEP Reports · 2024
  33. Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis using reconstructed RCT survival dataJHEP Reports · 2024
  34. Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosisJHEP Reports · 2024
  35. Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrenceJHEP Reports · 2024
  36. Validation of the Chronic Liver Disease Questionnaire for MASH (CLDQ-MASH)JHEP Reports · 2024
  37. Single-cell analyses reveal metastasis mechanism and microenvironment remodeling of lymph node in intrahepatic cholangiocarcinomaJHEP Reports · 2024
  38. PreS1 deletions in genotype C HBV leads to severe hepatic inflammation and hepatocarcinogenesis via the IRE1-JNK axisJHEP Reports · 2024
  39. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021JHEP Reports · 2024
  40. Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cellsJHEP Reports · 2024
  41. Microwave ablation vs. single-needle radiofrequency ablation for the treatment of HCC up to 4 cm: A randomized-controlled trialJHEP Reports · 2024
  42. AI-based tumor-infiltrating lymphocyte scoring system for assessing HCC prognosis in patients undergoing liver resectionJHEP Reports · 2024
  43. Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progressionJHEP Reports · 2024
  44. Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohortJHEP Reports · 2024
  45. Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptorsJHEP Reports · 2024
  46. Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024JHEP Reports · 2024
  47. Human GM-CSF/IL-3 enhance tumor immune infiltration in humanized HCC patient-derived xenograftsJHEP Reports · 2024
  48. Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studiesJHEP Reports · 2024
  49. MetALD: Clinical aspects, pathophysiology and treatmentJHEP Reports · 2024
  50. Alcohol-associated hepatitis trends before and following the onset of the COVID-19 pandemic across two distinct cohorts in the United States and Hong KongJHEP Reports · 2024